Product Description
Since last manyyears Saintroy Lifescience is leading manufacture, export and supplierofCarboplatin Injectionfrom Surat, Gujarat, India. Carboplatin Injection used to treat a number of forms of cancer. This includes ovarian cancer, lung cancer, head and neck cancer, brain cancer, and neuroblastoma.
Tags: Carboplatin Injection manufacturer, Carboplatin Injection exporter,Carboplatin Injection supplier, and Carboplatin Injection, whogmp approved Carboplatin Injectionmanufacturer and supplier, Carboplatin Injection distributor, Carboplatin Injectionshipper, Carboplatin Injection 5 ml Carboplatin Injection 5 ml supplier,Carboplatin Injection 5 ml.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturing facility inGujarat, India.
Registration: Saintroy Lifescience is interested inregistration of own brand or customer brands in ministry of health of clientscountry and we also provide the products samples, COA, COPP, ACTD or CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country :Saintroy Lifescience Carboplatin Injectionexport to USA, Canada, Germany, Europe, France, Ghana, Nigeria,Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile,Somalia, Philippines, Myanmar, Maldives, Thailand, Singapore, Malaysia, HongKong, China, Zimbabwe, Togo, Burkina Faso, Niger,Guinea Bissau, Congo,Democratic of republic, Ivory Costa, Oman, Guatemala, Nicaragua, Salvador,Qatar, Costa Rica, Panama, Cuba, Colombia, Bolivia, Argentine, Algeria, Guyana,Morocco, Jordan, Bahrain, Iran, Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.
Effective Chemotherapy SolutionCarboplatin Injection is widely recognized for its efficacy in the treatment of ovarian cancer and several other types of malignancies. This platinum-based chemotherapeutic agent disrupts cancer cell replication, enhancing patient prognosis and increasing treatment options for healthcare providers.
Formulation and Quality AssuranceManufactured in India, each Carboplatin Injection vial is processed under stringent quality standards. The glass vial ensures product integrity, while the clear, colorless to slightly yellow solution stays stable for up to two years if stored at recommended conditions. Its neutral pH and complete miscibility with water makes it suitable for clinical settings.
Safe and Convenient AdministrationThe product is formulated specifically for intravenous (IV) infusion, making it suitable for controlled hospital administration. The compatibility with 5% Dextrose Injection streamlines preparation in healthcare environments. Each dose is designed for single use to prevent contamination and ensure patient safety.
FAQ's of Carboplatin Injection:
Q: How should Carboplatin Injection be administered?
A: Carboplatin Injection is intended only for intravenous (IV) infusion and must be administered under the supervision of qualified healthcare professionals. It is typically diluted with a compatible fluid such as 5% Dextrose Injection before being slowly infused into a vein.
Q: What are the main indications for using Carboplatin Injection?
A: This injection is primarily used in the treatment of ovarian cancer and may be prescribed for other malignancies as determined by a healthcare provider.
Q: When should Carboplatin Injection not be used?
A: Carboplatin Injection should not be used in individuals who have a known hypersensitivity to carboplatin or other platinum-containing compounds. Patients should always consult a physician before starting treatment.
Q: Where should Carboplatin Injection be stored?
A: Store the Carboplatin Injection in a cool, dry place and keep it out of direct sunlight. Always ensure it is kept away from children and unauthorized access.
Q: What is the process for preparing Carboplatin Injection for administration?
A: The solution needs to be diluted, usually with 5% Dextrose Injection, and prepared using aseptic techniques by trained medical staff before administering it as an IV infusion.
Q: How does Carboplatin Injection benefit patients?
A: Carboplatin inhibits the growth of cancer cells by interfering with their DNA replication. This can slow disease progression and improve treatment outcomes, particularly for ovarian cancer patients.